Detalles de la búsqueda
1.
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.
Oncologist;
27(4): 292-298, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380713
2.
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Breast Cancer Res Treat;
189(1): 103-110, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34120223
3.
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
JAMA;
321(14): 1370-1379, 2019 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30964527
4.
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial.
Cancers (Basel);
12(11)2020 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33233566
5.
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.
JAMA Oncol;
3(8): 1043-1050, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28208174
6.
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.
J Clin Oncol;
34(6): 542-9, 2016 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26527775
7.
Assessment of perceived cost to the patient and other barriers to clinical trial participation.
J Oncol Pract;
7(5): 330-3, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22211132
Resultados
1 -
7
de 7
1
Próxima >
>>